CONSUN PHARMAC.GR.HD -10 Cash Flow-to-Debt Ratio
CONSUN PHARMAC.GR.HD -10 cash flow-to-debt ratio. CONSUN PHARMAC.GR.HD -10 (C1P) has a Cash Flow-to-Debt Ratio of 0.77x as of December 2025, meaning its operating cash flow of €1.21 Billion could theoretically repay 1% of its total liabilities (€1.57 Billion) in one year. Check C1P operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CONSUN PHARMAC.GR.HD -10 (2021–2025)
Cash flow-to-debt ratio of CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. Historical debt coverage capacity for CONSUN PHARMAC.GR.HD -10 across 5 annual periods. Check CONSUN PHARMAC.GR.HD -10 (C1P) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CONSUN PHARMAC.GR.HD -10 Cash Flow-to-Debt Ratio by Year (2021–2025)
CONSUN PHARMAC.GR.HD -10 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for CONSUN PHARMAC.GR.HD -10. For the full cash flow conversion analysis, see CONSUN PHARMAC.GR.HD -10 (C1P) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.77x | €1.21 Billion | €1.57 Billion | ▲ +3.5% |
| 2024 | 0.74x | €1.09 Billion | €1.46 Billion | ▲ +44.5% |
| 2023 | 0.52x | €818.97 Million | €1.59 Billion | ▼ -21.0% |
| 2022 | 0.65x | €947.68 Million | €1.45 Billion | ▲ +30.5% |
| 2021 | 0.50x | €725.54 Million | €1.45 Billion | — |